Otosclerosis in Children Under 12 Years: First-Line Treatment Approach

When otosclerosis is diagnosed in a patient younger than 12 years of age, the management approach differs meaningfully from adult care. The child's ongoing skeletal growth creates specific considerations that must guide every prescribing decision.

Clinical Scenario

Patient age less than 12 years. Because of the increase in bone volume in this age group, dosing must be reduced according to body weight, and treatment should be prescribed only in consultation with the pediatrician.

Treatment Overview

First-line management involves an oral agent with dosing individually adjusted for the child's body weight, initiated only under pediatric oversight — the full dosing approach and prescribing conditions are detailed in the complete protocol.

Full regimen, sequencing, and prescribing criteria available via the protocol below.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1016/j.otc.2017.11.006

In children less than 12 years of age, the dosage should be reduced according to their weight because of the increase in bone volume in this age group and should be prescribed only in consultation with the pediatrician.

After puberty, the adult dose may be initiated.

View source ↗